company background image
RMD logo

ResMed WBAG:RMD Stock Report

Last Price

€222.10

Market Cap

€32.9b

7D

-0.4%

1Y

42.5%

Updated

30 Dec, 2024

Data

Company Financials +

ResMed Inc.

WBAG:RMD Stock Report

Market Cap: €32.9b

RMD Stock Overview

Develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. More details

RMD fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance6/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 35.7% below our estimate of its fair value

Earnings are forecast to grow 11.11% per year

Earnings grew by 22.8% over the past year

Risk Analysis

Significant insider selling over the past 3 months


My Notes

Capture your thoughts, links and company narrative

ResMed Inc. Competitors

IDEXX Laboratories

NasdaqGS:IDXX

US$34.0b

Terumo

TSE:4543

JP¥4.5t

DexCom

NasdaqGS:DXCM

US$31.3b

Shenzhen Mindray Bio-Medical Electronics

SZSE:300760

CN¥313.0b

Price History & Performance

Summary of share price highs, lows and changes for ResMed
Historical stock prices
Current Share PriceUS$222.10
52 Week HighUS$239.00
52 Week LowUS$151.20
Beta0.68
1 Month Change-5.53%
3 Month Change1.93%
1 Year Change42.51%
3 Year Change-2.33%
5 Year Change59.78%
Change since IPO142.84%

Recent News & Updates

Recent updates

Shareholder Returns

RMDAT Medical EquipmentAT Market
7D-0.4%-0.2%1.1%
1Y42.5%5.8%-0.6%

Return vs Industry: RMD exceeded the Austrian Medical Equipment industry which returned 6.7% over the past year.

Return vs Market: RMD exceeded the Austrian Market which returned -1.1% over the past year.

Price Volatility

Is RMD's price volatile compared to industry and market?
RMD volatility
RMD Average Weekly Movement3.9%
Medical Equipment Industry Average Movement6.2%
Market Average Movement3.6%
10% most volatile stocks in AT Market6.2%
10% least volatile stocks in AT Market2.3%

Stable Share Price: RMD has not had significant price volatility in the past 3 months compared to the Austrian market.

Volatility Over Time: RMD's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19899,980Mick Farrellwww.resmed.com

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.

ResMed Inc. Fundamentals Summary

How do ResMed's earnings and revenue compare to its market cap?
RMD fundamental statistics
Market cap€32.95b
Earnings (TTM)€1.07b
Revenue (TTM)€4.63b

30.7x

P/E Ratio

7.1x

P/S Ratio

Is RMD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RMD income statement (TTM)
RevenueUS$4.81b
Cost of RevenueUS$2.00b
Gross ProfitUS$2.80b
Other ExpensesUS$1.69b
EarningsUS$1.11b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)7.58
Gross Margin58.33%
Net Profit Margin23.15%
Debt/Equity Ratio13.0%

How did RMD perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

26%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 08:06
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ResMed Inc. is covered by 56 analysts. 24 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John HesterANZ Equities Pty Limited
David RescottBaird
Michael PolarkBaird